<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01935440</url>
  </required_header>
  <id_info>
    <org_study_id>R01DA032217</org_study_id>
    <secondary_id>R01DA032217</secondary_id>
    <nct_id>NCT01935440</nct_id>
  </id_info>
  <brief_title>A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives</brief_title>
  <acronym>P&amp;T</acronym>
  <official_title>A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins Bloomberg School of Public Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins Bloomberg School of Public Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to conduct an HIV prevention intervention to train HIV seropositive&#xD;
      drug users to be peer health educators.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this funded research is to conduct an HIV prevention intervention to&#xD;
      train HIV seropositive drug users to be peer health educators to: (1) recruit their high risk&#xD;
      social network members for voluntary HIV counseling and testing (VCT) at the research clinic,&#xD;
      (2) promote risk reduction among social network members, and (3) promote engagement in HIV&#xD;
      care by encouraging HIV seropositive network members to schedule and keep HIV primary care&#xD;
      appointments. There will be four types of participants in the Full Trial: 1) Index, 2)&#xD;
      Testing Network 3) Longitudinal Network and 4) HIV positive network participants. This&#xD;
      longitudinal study includes baseline, 6-months, and 12-month assessments&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2012</start_date>
  <completion_date type="Actual">January 31, 2017</completion_date>
  <primary_completion_date type="Actual">January 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in HIV medication adherence</measure>
    <time_frame>6 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>change in frequency in attending HIV medical appointments</measure>
    <time_frame>6 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in sharing injection equipment</measure>
    <time_frame>6 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in condom use</measure>
    <time_frame>6 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">632</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>Prevention &amp; Testing Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The comparison condition is focused on basic HIV risk reduction , safety and preventing drug overdose.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prevention &amp; Testing Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention condition is training on peer outreach skills which includes talking to HIV positive social network members about HIV care, medication adherence and HIV risk reduction.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Prevention &amp; Testing</intervention_name>
    <description>6 group sessions, 1 individual session, and 1 dyad session</description>
    <arm_group_label>Prevention &amp; Testing Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Prevention &amp; Testing Control</intervention_name>
    <description>7 group sessions</description>
    <arm_group_label>Prevention &amp; Testing Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Index&#xD;
&#xD;
          1. 18 years old or older&#xD;
&#xD;
          2. documentation of HIV positive status&#xD;
&#xD;
          3. report one of following risk behaviors in past 90 days: sharing injection equipment,&#xD;
             use of crack cocaine, or unprotected vaginal or anal sex&#xD;
&#xD;
        Testing network&#xD;
&#xD;
          1. 18 or older&#xD;
&#xD;
          2. provided testing coupon provided by an index participant&#xD;
&#xD;
        Longitudinal network participant-&#xD;
&#xD;
          1. tested HIV negative at the Lighthouse via redeeming a testing coupon&#xD;
&#xD;
          2. reported interacting with index who gave the coupon at least weekly&#xD;
&#xD;
          3. report one of following risk behaviors in the prior 90 days: sharing injection&#xD;
             equipment, use of crack cocaine, or unprotected vaginal or anal sex&#xD;
&#xD;
        Positive Networks&#xD;
&#xD;
          1. HIV positive&#xD;
&#xD;
          2. report one of following risk behaviors in the prior 90 days: sharing injection&#xD;
             equipment, use of crack cocaine, or unprotected vaginal or anal sex&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Index- already enrolled in the study as a Network participant&#xD;
&#xD;
        Testing network- already enrolled in the study as a Network participant&#xD;
&#xD;
        Longitudinal network- a) already enrolled in the study as a Network participant b) already&#xD;
        enrolled in the study as a Index participant&#xD;
&#xD;
        Positive network- a) already enrolled in the study as a Network participant b) already&#xD;
        enrolled in the study as a Index participant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carl A Latkin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins Bloomberg School of Public Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lighhouse Studies @ Peer Point</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>August 20, 2013</study_first_submitted>
  <study_first_submitted_qc>August 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2013</study_first_posted>
  <last_update_submitted>July 6, 2018</last_update_submitted>
  <last_update_submitted_qc>July 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins Bloomberg School of Public Health</investigator_affiliation>
    <investigator_full_name>Carl Latkin</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>HIV, drug use</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

